Heparin and heparan sulfate: Biosynthesis, structure and function

Current Opinion in Chemical Biology

Volumn 4, Issue 6, 2000, Pages 626-631

  Sasisekharan, Ram ^a,b   Venkataraman, Ganesh ^a,c  

^a Division of Bioengineering and Environmental Health   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN;

BINDING SITE; BIOSYNTHESIS; CHEMICAL COMPOSITION; CONFORMATION; NUCLEAR MAGNETIC RESONANCE; PROTEIN INTERACTION; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

EID: 0033635310     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(00)00145-9     Document Type: Review

References (51)

1. Specificities of heparan sulphate proteoglycans in developmental processes
2. On the regulation of fibroblast growth factor activity by heparin-like glycosaminoglycans
3. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
4. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry
5. Synthesis of thrombin-inhibiting heparin mimetics without side effects
6. Heparin is essential for the storage of specific granule proteases in mast cells
7. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme
8. The cell-surface proteoglycan Dally regulates wingless signalling in Drosophila
9. Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling
10. Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
11. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
12. Matrix proteoglycans: From molecular design to cellular function
13. Growth factors in the extracellular matrix
14. Regulated diversity of heparan sulfate
15. Heparan sulfate proteoglycans on the cell surface: Versatile coordinators of cellular functions
16. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1
17. Overexpression of different isoforms of glucosaminyl N-deacetylase/N-sulfotransferase results in distinct heparan sulfate N-sulfation patterns
18. Demonstration of glycosaminoglycans in Caenorhabditis elegans
19. Location of the glucuronosyltransferase domain in the heparan sulfate copolymerase EXT1 by analysis of Chinese hamster ovary cell mutants
20. The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate
21. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus
22. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?
23. Diversity and functions of glycosaminoglycan sulfotransferases
24. Heparinoids: Structure, biological activities and therapeutic applications
25. Microanalysis of glycosaminoglycan-derived oligosaccharides labeled with a fluorophore 2-aminobenzamide by high-performance liquid chromatography: Application to disaccharide composition analysis and exosequencing of oligosaccharides
26. Sequence analysis of heparan sulphate and heparin oligosaccharides
27. Mass spectrometric molecular-weight determination of highly acidic compounds of biological significance via their complexes with basic polypeptides
28. Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans
29. Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I
30. Mass spectrometric evidence for the enzymatic mechanism of the depolymerization of heparin-like glycosaminoglycans by heparinase II
31. A strategy for rapid sequencing of heparan sulfate and heparin saccharides
32. Highly sensitive sequencing of the sulfated domains of heparan sulfate
33. Sequencing complex polysaccharides
34. Controversial glycosaminoglycan conformations
35. NMR solution conformation of heparin-derived hexasaccharide
36. Pyranose ring flexibility. Mapping of physical data for iduronate in continuous conformational space
37. NMR And molecular-modelling studies of the solution conformation of heparin
38. Diversity does make a difference: Fibroblast growth factor-heparin interactions
39. Solution structure of acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide
40. Structure of a heparin-linked biologically active dimer of fibroblast growth factor
41. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex
42. Structure of heparin-derived tetrasaccharide complexed to the plasma protein antithrombin derived from NOEs, J-couplings and chemical shifts
43. The anticoagulant activation of antithrombin by heparin
44. Structural studies of protein-nucleic acid interaction: The sources of sequence-specific binding
45. A novel strategy to generate biologically active neo-glycosaminoglycan conjugates
46. Sequencing of 3-O sulfate containing decasaccharides with a partial antithrombin III binding site
47. Cleavage of the antithrombin III binding site in heparin by heparinases: Implication in the generation of low molecular weight heparin
48. Heparin sequencing brings structure to the function of complex oligosaccharides
49. Direct isolation and sequencing of specific protein-binding glycosaminoglycans on a chip